课题基金 / 基金详情

Development of a novel circular economy plant protein derivative as a readily digestible dietary ingredient to support healthy ageing

Development of a novel circular economy plant protein derivative as a readily digestible dietary ingredient to support healthy ageing
开发新型循环经济植物蛋白衍生物作为易于消化的膳食成分以支持健康老龄化
批准号:
10073099
负责人:
金额:
$36.55万
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Sarcopenia, or the decline of skeletal muscle tissue with age, is one of the most important causes of functional decline, frailty and loss of independence in older adults leading to increased hospitalizations and mortality rates. There will be ~2Bn people over the age of 65 by 2050 representing the world's fastest growing age-group with a corresponding increase of 68% in the incidence of sarcopenia. However, as life expectancy continues to increase, older demographics are likely to play more significant roles in societies and economies.Adequate nutrition and targeted exercise remain the gold standard for the therapeutic treatment of sarcopenia. The annual cost to the NHS of treating age-related musculoskeletal decline is estimated at £5.7 billion (5% of net expenditure) and in the United States, sarcopenia has been estimated to have an economic burden related to health care expenditures of $18.5 billion per year. Commercially, the global sarcopenia treatments market size was estimated at $2.8 billion in 2022 and is projected to reach $3.8 billion by 2028, exhibiting a compound annual growth rate (CAGR) of ~4.7% during the forecast period.Bell & Loxton Innovations Ltd is addressing this growing health challenge by developing an easily digestible, sustainable plant-based food ingredient, that can be incorporated into normal food via fortification or as a standalone food supplement. The ability to digest various food groups decreases with age which is further compounded by the need to consume a greater amount of certain nutrient classes than a younger person to maintain health and strength. B&LI is a circular economy company which innovates through extracting high-value biorenewables from abundant agri-food waste streams to create active ingredients of therapeutic and nutritional value. Our plant-based product will be made available to seniors to contribute towards a healthy diet that supports mobility and strength and prolongs independent living thereby reducing the burden on the NHS and the wider care system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: